ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Swiss food giant Nestlé says it will collaborate with Dublin-based start-up Nuritas to find bioactive peptides hidden in foods. These health-promoting peptides can be added to functional foods for people with certain medical conditions.
When people drink a glass of milk, their bodies use milk proteins to produce useful stuff like muscles and DNA. But the proteins in food also contain short stretches of amino acids—or peptides—that perform important functions such as fighting inflammation or modulating the immune system.
Normally these bioactive peptides are released from the larger proteins by gut bacteria using hydrolysis. Food and food ingredient companies would like to find the peptides and make them in much larger quantities. Nuritas says it can predict their presence in food and then access them using artificial intelligence and genomics.
A year ago, Nuritas licensed one of its already-discovered peptides to BASF. The German chemical firm says it will be part of an anti-inflammatory sports nutrition ingredient it plans to launch later this year.
In December, Nuritas raised $20 million in its first round of funding led by Cultivian Sandbox Ventures. Earlier investors include Bono and The Edge, two members of the Irish rock band U2.
While Nestle would not comment on what health conditions it plans to target, Nuritas says it is seeking peptides that could prevent diabetes. The company points to statistics showing that more than 350 million people have prediabetes. Roughly 34 million of them will go on to develop the full-blown condition.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter